HIV Pathogenesis and Immunity in Viremic Non-Progressors
病毒血症非进展者的 HIV 发病机制和免疫
基本信息
- 批准号:8069963
- 负责人:
- 金额:$ 18.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-05-15 至 2013-04-30
- 项目状态:已结题
- 来源:
- 关键词:AIDS VaccinesAcquired Immunodeficiency SyndromeAffectBiologicalBiological AssayBloodCCR5 geneCD14 geneCD4 Positive T LymphocytesCell SeparationCellsCercocebusCercopithecus pygerythrusConceptionsDataDiseaseFetal Thymic Organ CultureGaggingGenomeHIVHIV-1Highly Active Antiretroviral TherapyImmuneImmune responseImmunityImmunophenotypingIndividualInfectionIntegrinsLaboratoriesMeasuresMemoryPathogenesisPatientsPeptidesPeripheral Blood Mononuclear CellPhenotypePlasmaProcessRNASIVSerumStagingT cell responseT-Lymphocyte SubsetsTestingTherapeutic AgentsViralViral Load resultViremiacohortdesignimmune activationin vivointerestmemory CD4 T lymphocytemicrobialperipheral bloodpreventpublic health relevanceresponsevaccine development
项目摘要
DESCRIPTION (provided by applicant): Very rare HIV-1 infected individuals retain effective levels of CD4+ T cells and remain asymptomatic despite consistent viral loads greater than 104 or even 105 HIV-1 RNA copies/ml plasma. This extremely unusual, favorable response to HIV-1 infection remains incompletely characterized. Our initial study of three such viremic non-progressors (VNP) showed a lack of non-specific immune activation and consistent CD4+ T cell responses to HIV-1 despite the presence of replication competent, cytopathic R5 HIV-1. VNP therefore mimic the immune response of natural hosts of SIV that do not develop disease, including the sootey mangabey and African green monkey. Developing a detailed understanding of how these rare individuals remain healthy despite high HIV-1 load will be extremely useful in understanding the normal process of HIV-1 pathogenesis and in developing new treatments or vaccines for AIDS. We hypothesize that the VNP phenotype is caused by replication competent but weakly cytopathic HIV-1 or by effective immunity that maintains the mucosal barrier and prevents non-specific immune activation. To test this dual hypothesis we have three specific aims: 1. Isolate and characterize the replication and cytopathic effects of HIV-1 from VNP in PBMC and fetal thymic organ culture, 2. Characterize VNP PBMC subsets by immunophenotyping and cell sorting plus HIV-1 QPCR to discern whether immune subsets or the distribution of HIV-1 differ from other HIV-1 infected individuals, 3. Assay immune activation, serum LPS levels and soluble CD14 levels as well as specific HIV T cell responses in fresh PBMC from VNP compared with controls.
PUBLIC HEALTH RELEVANCE: HIV Pathogenesis and Immunity in Viremic Non-Progressors Very rare HIV-1 infected individuals retain effective levels of CD4+ T cells and remain disease free despite consistent high viral. This extremely unusual, favorable response to HIV-1 infection remains incompletely characterized. Developing a detailed understanding of how these rare individuals remain healthy despite high HIV-1 load will be extremely useful in understanding the normal process of HIV-1 pathogenesis and in developing new treatments or vaccines for AIDS.
描述(由申请人提供):非常罕见的 HIV-1 感染者保留有效水平的 CD4+ T 细胞,并且尽管病毒载量持续高于 104 甚至 105 HIV-1 RNA 拷贝/ml 血浆,但仍保持无症状。这种对 HIV-1 感染的极其不寻常的有利反应仍未完全表征。我们对三个此类病毒血症非进展细胞 (VNP) 的初步研究表明,尽管存在复制能力、细胞病变的 R5 HIV-1,但缺乏非特异性免疫激活和对 HIV-1 的一致 CD4+ T 细胞反应。因此,VNP 模仿了不发病的 SIV 天然宿主的免疫反应,包括白眉猴和非洲绿猴。详细了解这些稀有个体如何在 HIV-1 载量较高的情况下保持健康,对于了解 HIV-1 发病机制的正常过程以及开发艾滋病新疗法或疫苗非常有用。我们假设 VNP 表型是由具有复制能力但细胞病变性较弱的 HIV-1 引起的,或者是由维持粘膜屏障并防止非特异性免疫激活的有效免疫引起的。为了检验这一双重假设,我们有三个具体目标:1. 分离并表征 PBMC 和胎儿胸腺器官培养物中 VNP 的 HIV-1 复制和细胞病变效应,2. 通过免疫表型分析和细胞分选加上 HIV-1 QPCR 来表征 VNP PBMC 子集,以辨别免疫子集或 HIV-1 的分布是否与其他 HIV-1 感染个体不同,3. 免疫分析 与对照相比,来自 VNP 的新鲜 PBMC 中的活化、血清 LPS 水平和可溶性 CD14 水平以及特异性 HIV T 细胞反应。
公共卫生相关性:病毒血症非进展者的 HIV 发病机制和免疫 非常罕见的 HIV-1 感染者保留有效水平的 CD4+ T 细胞,并且尽管病毒持续处于高水平,但仍保持无病状态。这种对 HIV-1 感染的极其不寻常的有利反应仍未完全表征。详细了解这些稀有个体如何在 HIV-1 载量较高的情况下保持健康,对于了解 HIV-1 发病机制的正常过程以及开发艾滋病新疗法或疫苗非常有用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID CAMERINI其他文献
DAVID CAMERINI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID CAMERINI', 18)}}的其他基金
Identification of Serodiagnostic Epitopes for SARS-CoV-2, endemic HCoV?s and influenza virus
SARS-CoV-2、地方性 HCoV 和流感病毒血清诊断表位的鉴定
- 批准号:
10259177 - 财政年份:2021
- 资助金额:
$ 18.97万 - 项目类别:
Discovery of Yellow Fever Virus-Specific Epitopes for Development of an Accurate Serodiagnostic Assay
发现黄热病病毒特异性表位以开发准确的血清诊断测定
- 批准号:
9467246 - 财政年份:2018
- 资助金额:
$ 18.97万 - 项目类别:
Specific Detection of Antibodies to Emerging and Established Arboviruses Including Zika Virus
针对新出现和已建立的虫媒病毒(包括寨卡病毒)的抗体的特异性检测
- 批准号:
9347926 - 财政年份:2017
- 资助金额:
$ 18.97万 - 项目类别:
HIV Pathogenesis and Immunity in Viremic Non-Progressors
病毒血症非进展者的 HIV 发病机制和免疫
- 批准号:
7931065 - 财政年份:2010
- 资助金额:
$ 18.97万 - 项目类别:
Defensin mediated inhibition of HIV-1 replication
防御素介导的 HIV-1 复制抑制
- 批准号:
6954219 - 财政年份:2004
- 资助金额:
$ 18.97万 - 项目类别:
Defensin mediated inhibition of HIV-1 replication
防御素介导的 HIV-1 复制抑制
- 批准号:
6845911 - 财政年份:2004
- 资助金额:
$ 18.97万 - 项目类别:
HIV-1 Clones with Attenuated Cytopathic Effects
细胞病变效应减弱的 HIV-1 克隆
- 批准号:
6744170 - 财政年份:2003
- 资助金额:
$ 18.97万 - 项目类别:
HIV-1 Clones with Attenuated Cytopathic Effects
细胞病变效应减弱的 HIV-1 克隆
- 批准号:
6655454 - 财政年份:2003
- 资助金额:
$ 18.97万 - 项目类别:
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 18.97万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 18.97万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 18.97万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 18.97万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 18.97万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 18.97万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 18.97万 - 项目类别: